Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cognyte Software Ltd (NQ: CGNT )

7.865 -0.265 (-3.26%)
Streaming Delayed Price Updated: 12:02 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cognyte Software Ltd

< Previous 1 2 3 4 5 6 7 Next >
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
ONGOING INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Announces Investigation into Cognyte Software Ltd. (CGNT)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
What 4 Analyst Ratings Have To Say About Cognyte Software
Analysts have provided the following ratings for Cognyte Software (NASDAQ:CGNT) within the last quarter: 
Via Benzinga
Here's Why Cognyte Software Shares Are Crashing Premarket
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
Upgrades 
Via Benzinga
Amazon To $140? Here's The Biggest Price Target Changes For Wednesday
Barclays cut NIKE, Inc. (NYSE: NKE) price target from $140 to $125. Nike shares fell 0.6% to $102.17 in pre-market trading. 
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Dow Dips Over 400 Points; Crude Oil Rises 2%
U.S. stocks turned sharply lower toward the end of trading, with the Dow Jones dropping more than 400 points on Tuesday. 
Via Benzinga
Nasdaq Turns Lower; Kezar Life Sciences Shares Jump
U.S. stocks pared gains midway through trading, with the Nasdaq Composite and S&P 500 turning lower on Tuesday. 
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Cognyte Software (CGNT) Stock Plummets 30% on Disappointing Earnings
Cognyte Software CEO Elad Sharon says he's disappointed with the company's Q1 results. Clearly, CGNT stock investors are disappointed, too. 
Via InvestorPlace
Markets Open Higher; US Goods Gap Narrows To $104.3B In May
U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday. 
Via Benzinga
Recap: Cognyte Software Q1 Earnings
Cognyte Software (NASDAQ:CGNT) reported its Q1 earnings results on Tuesday, June 28, 2022 at 07:10 AM. Here's what investors need to know about the announcement. Earnings Cognyte Software reported an... 
Via Benzinga
Cognyte Announces First Quarter Results
From Cognyte Software Ltd.
Via Business Wire
Earnings Scheduled For June 28, 2022
Companies Reporting Before The Bell • Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter. 
Via Benzinga
Preview: Cognyte Software's Earnings
Cognyte Software (NASDAQ:CGNT) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement. Analysts estimate that Cognyte... 
Via Benzinga
Cognyte to Announce First Quarter FY2023 Financial Results on June 28, 2022
From Cognyte Software Ltd.
Via Business Wire
NASDAQ: CGNT Investor Alert: Investigation over Possible Securities Laws Violations by Cognyte Software Ltd.
San Diego, CA -- (SBWIRE) -- 06/16/2022 -- An investigation for investors in Cognyte Software Ltd. (NASDAQ: CGNT) shares over potential securities laws violations by Cognyte Software Ltd. was... 
Via SBWire
INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Announces Investigation into Cognyte Software Ltd. (CGNT)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
COGNYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Cognyte Software Ltd. on Behalf of Cognyte Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Business Wire
COGNYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Cognyte Software Ltd. on Behalf of Cognyte Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into Cognyte Software Ltd. (CGNT)
NEW YORK, NY / ACCESSWIRE / June 3, 2022 / Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international shareholder and consumer rights litigation firm, is investigating whether Cognyte Software... 
From Scott+Scott Attorneys at Law LLP
Via AccessWire
Topics Economy
Exposures Supply Chain
Cognyte Expands its Strategic Partner Program to Drive Business Growth
From Cognyte
Via Business Wire
Analyst Ratings For Cognyte Software
Over the past 3 months, 4 analysts have published their opinion on Cognyte Software (NASDAQ:CGNT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.